Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
463-05-001.
Diagnostic performance of MR imaging findings and quantitative values in the differentiation of BEOTs and type I EOC
Impact: Mean ADC values of tumour solid tissue and maximal diameter of solid tissue were useful for differentiating BEOTs from type I EOC. These two indicators are readily available during routine pelvic MRI examinations and can aid in clinical decision making.
|
||
|
463-05-002.
PSMA-PET/MRI Tracers in Prostate Cancer Recurrence: Superior Sensitivity of [¹⁸F]F-PSMA-1007 at Low PSA Levels.
Impact: This study supports [¹⁸F]F-PSMA-1007 as the preferred tracer for detecting recurrent prostate cancer at low PSA levels, potentially improving early localization and guiding salvage therapy decisions in clinical practice.
|
||
|
463-05-003.
DCE-MRI Identifies Responders: Post-Ktrans Outperforms in Predicting Pathologic Complete Response in Esophageal Carcinoma
Impact: Post-Ktrans provides a robust non-invasive imaging biomarker to accurately identify patients who
achieve pCR, potentially supporting clinical decisions to omit surgery in favor
of organ-preservation strategies, thereby reducing treatment morbidity without
compromising oncological outcomes.
|
||
|
463-05-004.
Comparative evaluation of ZOOMit diffusion-weighted imaging and conventional DWI in esophageal cancer
Impact: This study demonstrates
that ZOOMit DWI enables clearer visualization of lesion characteristics and
more accurate assessment, potentially enhancing the diagnostic efficiency of
esophageal cancer and supporting more precise treatment planning.
|
||
|
463-05-005.
Transverse relaxation time and cellular proliferative activity in breast tumour on 3T using Bayesian two-compartment analysis
Impact: Transverse relaxation times from two-compartment model and Bayesian algorithm offers a potential marker of proliferative activity, supporting early and non-invasive approach for monitoring response to neoadjuvant therapy in breast cancer.
|
||
|
463-05-006.
Comparison of Conventional ADC Values and Params of FROC Model in Predicting Breast Lesion Benign/Malignant
Impact: The
study confirms the added value of FROC parameters in enhancing diagnostic
accuracy for breast lesions, offering a new imaging biomarker for precise
differentiation between benign and malignant breast pathology.
|
||
|
463-05-007.
Texture and Radiomic Feature Analysis in Breast MRI: Supervised Classification and Unsupervised Clustering of IDC and ILC
Impact: Breast MRI radiomics accurately distinguished
invasive ductal from lobular carcinoma using Random Forest classification.
PCA-based clustering further revealed receptor-linked subgroups. Key radiomic
features captured texture differences, demonstrating radiomics’ dual power in
precise tumor classification and biologically meaningful, unsupervised subgroup
discovery
|
||
|
463-05-008.
Utility of diffusion-weighted T2 mapping (DW-T2 mapping) for the diagnosis of breast cancer
Impact: Diffusion-weighted T2 mapping might be
useful as supportive information for the diagnosis of breast cancer.
|
||
|
463-05-009.
OGSE MRI for Tumor Grading of Colorectal Cancer: A Noninvasive Approach
Impact: OGSE-MRI
enables quantitative, noninvasive assessment of rectal tumor microstructure,
effectively distinguishing histologic grades. This technique provides a
promising imaging biomarker for preoperative risk stratification and could
support precision treatment planning without the need for invasive biopsy.
|
||
|
463-05-010.
Preoperative prediction of muscle invasion and CK20 expression in bladder cancer using multi-model diffusion MRI
Impact: Multi-model diffusion MRI can predict muscle invasion and CK20 expression, enabling personalized treatment planning and reducing reliance on invasive biopsy.
|
||
|
463-05-011.
Improved Diagnosis of Prostate Cancer Through Native Integration of Hybrid Multi-Dimensional MRI With PSMA-PET
Impact: Quantitative analysis and native integration of Hybrid
Multi-Dimensional MRI (HM-MRI) and PSMA-PET has the potential to improve the
diagnosis of prostate cancer and reveal tissue biology.
|
||
|
463-05-012.
Added Value of DKI and ADC for Enhancing PI-RADS v2.1 in Detecting Clinically Significant Prostate Cancer
Impact: In this
study, the diagnostic value of DKI parameters (MD, MK) and ADC values in
identifying csPCa was compared. All these parameters could have the potential to be used in
routine imaging diagnosis to improve the diagnostic performance of PI-RADS.
|
||
|
463-05-013.
MRMI assessment of therapeutic efficacy of P53-R175H targeting nanovaccine to treat pancreatic cancer
Impact: This study non-invasively monitored tumor microenvironment changes during nanovaccine immunotherapy by using MT218 to image extra domain B fibronectin. The correlation between contrast enhancement patterns and therapeutic outcomes provides a new biomarker and mechanistic insight.
|
© 2026 International Society for Magnetic Resonance in Medicine